These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26974266)

  • 1. Low Seroprevalence Indicates Vulnerability of Eastern and Central Sudan to Infection with Chikungunya Virus.
    Adam A; Seidahmed OM; Weber C; Schnierle B; Schmidt-Chanasit J; Reiche S; Jassoy C
    Vector Borne Zoonotic Dis; 2016 Apr; 16(4):290-1. PubMed ID: 26974266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.
    Kuan G; Ramirez S; Gresh L; Ojeda S; Melendez M; Sanchez N; Collado D; Garcia N; Mercado JC; Gordon A; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004773. PubMed ID: 27322692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Kankasha" in Kassala: A prospective observational cohort study of the clinical characteristics, epidemiology, genetic origin, and chronic impact of the 2018 epidemic of Chikungunya virus infection in Kassala, Sudan.
    Bower H; El Karsany M; Adam AAAH; Idriss MI; Alzain MA; Alfakiyousif MEA; Mohamed R; Mahmoud I; Albadri O; Mahmoud SAA; Abdalla OI; Eldigail M; Elagib N; Arnold U; Gutierrez B; Pybus OG; Carter DP; Pullan ST; Jacob ST; Abdallah TM; Gannon B; Fletcher TE
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009387. PubMed ID: 33930028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
    Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
    Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
    Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Chikungunya virus and living conditions in Feira de Santana, Bahia-Brazil.
    Teixeira MG; Skalinski LM; Paixão ES; Costa MDCN; Barreto FR; Campos GS; Sardi SI; Carvalho RH; Natividade M; Itaparica M; Dias JP; Trindade SC; Teixeira BP; Morato V; Santana EB; Goes CB; Silva NSJ; Santos CAST; Rodrigues LC; Whitworth J
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009289. PubMed ID: 33878115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and clinical manifestations of chikungunya virus infection in rural areas of Chandrapur, Maharashtra, India.
    Kawle AP; Nayak AR; Bhullar SS; Borkar SR; Patankar SD; Daginawala HF; Singh LR; Kashyap RS
    J Vector Borne Dis; 2017; 54(1):35-43. PubMed ID: 28352044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low chikungunya virus seroprevalence two years after emergence in Fiji.
    Aubry M; Kama M; Henderson AD; Teissier A; Vanhomwegen J; Mariteragi-Helle T; Paoaafaite T; Manuguerra JC; Christi K; Watson CH; Lau CL; Kucharski AJ; Cao-Lormeau VM
    Int J Infect Dis; 2020 Jan; 90():223-225. PubMed ID: 31689529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of chikungunya virus infection among febrile patients in northwest Ethiopia.
    Ferede G; Tiruneh M; Abate E; Wondimeneh Y; Gadisa E; Howe R; Aseffa A; Tessema B
    Int J Infect Dis; 2021 Mar; 104():183-188. PubMed ID: 33373719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Bead-Based Serologic Assay to Evaluate Chikungunya Virus Epidemic, Haiti.
    Rogier EW; Moss DM; Mace KE; Chang M; Jean SE; Bullard SM; Lammie PJ; Lemoine JF; Udhayakumar V
    Emerg Infect Dis; 2018 Jun; 24(6):995-1001. PubMed ID: 29774861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and entomological study on Chikungunya virus at the Croatian littoral.
    Vilibic-Cavlek T; Pem-Novosel I; Kaic B; Babić-Erceg A; Kucinar J; Klobucar A; Medic A; Pahor D; Barac-Juretic K; Gjenero-Margan I
    Acta Microbiol Immunol Hung; 2015 Jun; 62(2):199-206. PubMed ID: 26132839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
    Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
    J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: Results from a systematic review and a seroprevalence study in four locations.
    Quan TM; Phuong HT; Vy NHT; Thanh NTL; Lien NTN; Hong TTK; Dung PN; Chau NVV; Boni MF; Clapham HE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006246. PubMed ID: 29425199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.
    Shilpa C; Kavitha K; Sudheesh N; Sabeena S; Prasad V; Hindol M; Arunkumar G
    J Med Virol; 2020 Jan; 92(1):119-123. PubMed ID: 31463940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High seroprevalence of chikungunya virus antibodies among pregnant women living in an urban area in Benin, West Africa.
    Bacci A; Marchi S; Fievet N; Massougbodji A; Perrin RX; Chippaux JP; Sambri V; Landini MP; Varani S; Rossini G
    Am J Trop Med Hyg; 2015 Jun; 92(6):1133-6. PubMed ID: 25940198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based sero-prevalence of chikungunya and yellow fever in the South Omo Valley of Southern Ethiopia.
    Endale A; Michlmayr D; Abegaz WE; Asebe G; Larrick JW; Medhin G; Legesse M
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008549. PubMed ID: 32881913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.
    Hennessey MJ; Ellis EM; Delorey MJ; Panella AJ; Kosoy OI; Kirking HL; Appiah GD; Qin J; Basile AJ; Feldstein LR; Biggerstaff BJ; Lanciotti RS; Fischer M; Staples JE
    Am J Trop Med Hyg; 2018 Nov; 99(5):1321-1326. PubMed ID: 30226143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018.
    Luvai EAC; Kyaw AK; Sabin NS; Yu F; Hmone SW; Thant KZ; Inoue S; Morita K; Ngwe Tun MM
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009961. PubMed ID: 34851949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First reported chikungunya fever outbreak in the republic of Congo, 2011.
    Moyen N; Thiberville SD; Pastorino B; Nougairede A; Thirion L; Mombouli JV; Dimi Y; Leparc-Goffart I; Capobianchi MR; Lepfoundzou AD; de Lamballerie X
    PLoS One; 2014; 9(12):e115938. PubMed ID: 25541718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urban Chikungunya in the Middle East and North Africa: A systematic review.
    Humphrey JM; Cleton NB; Reusken CBEM; Glesby MJ; Koopmans MPG; Abu-Raddad LJ
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005707. PubMed ID: 28651007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.